NSE filing, NSE: MUTHOOTFIN. Summary written from the filing by ALFA Finder's alert engine.
Muthoot Finance Ltd: key numbers
- Share price
- ₹2,392.70
- Market cap
- ₹96,059 Cr
- Revenue (annual)
- ₹31,209 Cr
- Net profit (annual)
- ₹10,590 Cr
- P/E (TTM)
- 8.4×Sector 19.7×
- Promoter holding
- 73.35%+0.00% QoQ
- FII holding
- 9.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Muthoot Finance Ltd
All →Muthoot Finance Board Meeting Date
Muthoot Finance schedules a 31 October 2026 board meeting to consider September 2026 half-yearly results. Trading window closes from 1 October to 2 November 2026.
Muthoot Finance Other Announcement
Muthoot Finance Ltd has filed its routine quarterly shareholding pattern for the period ended September 30, 2026. This disclosure contains no material business event.
Muthoot Finance Debt & Borrowing
Muthoot Finance Limited announced the record dates for the redemption of three commercial paper issuances. The redemption process for these debt securities is scheduled for November 2026.
Muthoot Finance Debt & Borrowing: ₹459.7 Cr
Muthoot Finance completed full redemption of three secured NCD series, paying a total of Rs. 459.67 Crore to bondholders upon maturity.
- Value
- ₹459.7 Cr
Muthoot Finance Debt & Borrowing: ₹39.56 Cr
Muthoot Finance completed interest payments for four secured debenture series, totaling ₹39.56 Crore. These payments were made by the scheduled due dates.
- Value
- ₹39.56 Cr
Muthoot Finance Other Announcement
Muthoot Finance Limited submitted its quarterly certificate for Commercial Paper proceeds utilization. The company confirmed adherence to listing conditions for the period ended September 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.